Do not recommend Nine or any Chinese stocks

True: “True is in [Phase 3] for a very important indication for breast cancer. They just got the fast-track designation from the FDA this morning. It costs $ 5. It made no sense that the stock did not go up to me. I thought it should be on the news. ”

Nine: “No. Do not recommend it. Do not recommend any of the Chinese stocks. I especially do not like that stock. I just feel that there are people who want to speculate all the time on China. This is a different type of China than we are. “It is a communist country that no longer seems to favor capitalist development.”[ads1];

Grab Holdings: “We thought it was interesting when we looked at it. We like it. It has a lot more than just Uber. … I like the stock. I like it. We liked it when we looked at it.”

International Paper: “Cheap stock, but always a cheap stock. I do not want a stock that is always a cheap stock. I want a stock that moves higher.”

SMART Global Holdings: “I have to look at it again because this involves smartphones, and smartphones are under pressure here.”

Register now for the CNBC Investing Club to follow Jim Cramers every move in the market.

Disclaimer